INTERCEPT PHARMACEUTICALS IN (ICPT) Earnings History & Surprises
NASDAQ:ICPT • US45845P1084
19 USD
+0.04 (+0.21%)
At close: Nov 7, 2023
19 USD
0 (0%)
After Hours: 11/7/2023, 8:02:20 PM
Past quarterly earnings results for INTERCEPT PHARMACEUTICALS IN (ICPT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateFeb 29, 2024
PeriodQ4 / 2023
EPS Estimate$0.03
Revenue Estimate92.785M
Last Reported
Release DateNov 6, 2023
PeriodQ3 / 2023
EPS Reported$0.08
EPS Surprise 117.78%
Revenue Surprise -1.65%
Beat Rate
0%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | 0.08 | -0.45 | 117.78% | -98.97% | 88.789M | 90.28M | -1.65% | 14.44% |
| Q2 2023 | -0.14 | -0.52 | 73.02% | 79.41% | 83.718M | 81.158M | 3.15% | 16.67% |
| Q1 2023 | -0.77 | -0.66 | -16.57% | -32.76% | 67.958M | 73.664M | -7.75% | 14.90% |
| Q4 2022 | -0.50 | -0.16 | -203.66% | 59.35% | 77.219M | 79.638M | -3.04% | 12.51% |
| Q3 2022 | 7.80 | 4.70 | 66.01% | 1,338.10% | 77.588M | 75.549M | 2.70% | 16.43% |
| Q2 2022 | -0.68 | -0.50 | -36.76% | -106.06% | 71.757M | 97.639M | -26.51% | 5.25% |
| Q1 2022 | -0.58 | -0.92 | 36.95% | 52.46% | 59.146M | 91.5M | -35.36% | -27.57% |
| Q4 2021 | -1.23 | -1.12 | -9.94% | 22.15% | 68.633M | 94.233M | -27.17% | -17.58% |
| Q3 2021 | -0.63 | -1.11 | 43.37% | 60.87% | 66.64M | 84.676M | -21.30% | -16.20% |
| Q2 2021 | -0.33 | -1.24 | 73.43% | 82.81% | 68.178M | 84.338M | -19.16% | -11.74% |
| Q1 2021 | -1.22 | -1.47 | 17.08% | 57.34% | 81.66M | 82.839M | -1.42% | 12.40% |
| Q4 2020 | -1.58 | -1.50 | -5.09% | - | 83.27M | 86.706M | -3.96% | - |
| Q3 2020 | -1.61 | -1.97 | 18.30% | - | 79.52M | 80.202M | -0.85% | - |
| Q2 2020 | -1.92 | -2.97 | 35.44% | - | 77.25M | 73.592M | 4.97% | - |
| Q1 2020 | -2.86 | -2.96 | 3.38% | - | 72.65M | 71.055M | 2.24% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-7.36%
Max EPS beat (4)
117.78%
Min EPS beat (4)
-203.66%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-2.32%
Max Revenue beat (4)
3.15%
Min Revenue beat (4)
-7.75%
Analysis
In the last 4 quarters, ICPT has beaten EPS estimates in 2 out of 4 releases
ICPT has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, ICPT reported -7.4% below the EPS estimates on average.
In the last 4 quarters, ICPT reported -2.3% below the revenue estimates on average.
INTERCEPT PHARMACEUTICALS IN / ICPT Earnings FAQ
When did INTERCEPT PHARMACEUTICALS IN (ICPT) report earnings last quarter?
INTERCEPT PHARMACEUTICALS IN (ICPT) last reported earnings on 11/6/2023.
Can you provide information on whether INTERCEPT PHARMACEUTICALS IN beat earnings estimates in the last quarter?
INTERCEPT PHARMACEUTICALS IN (ICPT) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does INTERCEPT PHARMACEUTICALS IN (ICPT) beat earnings estimates?
In the last 4 quarters, INTERCEPT PHARMACEUTICALS IN (ICPT) has beaten EPS estimates in 2 out of 4 releases.